Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Wyoming for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Wyoming only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Wyoming (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Douglas Holmes (NPI 1073565487)

Field	Value
Entity Type	Individual
Organization	Douglas Holmes
Address	307 S Jackson St
City	Casper
State	WY
ZIP	82601
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	May 16, 2006

Payer Source	Total Paid
Medicare	$4.1M
Medicaid	$0

Key Findings

This provider is effectively a single‑payer Medicare practice: Total Medicare revenue is $4.1M and there is no Medicaid billing on file. The absence of Medicaid activity indicates limited exposure to state programs and that commercial or Medicare Advantage mix (not shown here) would be the only other payers beyond Medicare.

Revenue is highly concentrated in a small set of injectable retinal drugs: the precomputed top‑3 codes (J0178, J2777, J2778) account for 79.5% of this provider's total Medicare revenue. In dollars, J0178 accounts for $1.8M (44.2%), J2777 for $769.1K (18.8%), and J2778 for $674.3K (16.5%), so intravitreal pharmacologic therapy dominates the billing profile.

The code mix and descriptions identify the practice as a retina‑specialty operation centered on intravitreal anti‑VEGF and related biologic injections: J0178 (aflibercept), J2777 (faricimab), and J2778 (ranibizumab) together drive the majority of revenue. Supporting services that align with a retina workflow — high volumes of comprehensive established exams (92014) and posterior segment imaging (92134) — further indicate a care model built around frequent injection visits, imaging, and follow‑up.

Competitive standing on the main injection agents is mixed: J0178 ranks #278 of 3204 providers nationally (91th percentile; typical, unremarkable volume for this code) and J2777 ranks #354 of 2039 providers nationally (83th percentile; typical, unremarkable volume for this code), suggesting routine national participation in aflibercept and faricimab use. By contrast, J2778 ranks #77 of 1208 providers nationally (94th percentile; typical, unremarkable volume for this code), indicating relatively higher national intensity for ranibizumab among peers.

Office and imaging services are extreme outliers relative to national peers, consistent with high visit and diagnostic throughput: 92014 is #27 of 35415 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code) and 92134 is #121 of 26868 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code). Those listings point to substantially higher-than‑typical volumes of comprehensive established exams and retinal OCT imaging supporting the injection practice.

The practice also reports notable procedural retina activity beyond injections: 67028 (intravitreal injection as an isolated procedure) is $261.7K (6.4%) and ranks #148 of 4255 providers nationally (97th percentile; notably above typical national volume for this code), and smaller volumes are reported for surgical retina codes such as 67041 and 67108 at customary national rank positions. This mix implies the provider performs both high-volume injection clinics and a smaller but present surgical retina caseload.

Tenure and established presence are long: the NPI was enumerated on 2006-05-16 (~20 years ago), indicating the provider has been active and credentialed for roughly two decades, which supports the high outpatient throughput and entrenched referral patterns implied by the billing profile.

The concentration of revenue in the three injectable drug codes (79.5% concentrated) and the dominant contribution of a single code (J0178 at $1.8M, 44.2%) create a business profile that is highly dependent on anti‑VEGF utilization patterns and drug mix choices. From an analytic perspective, this concentration is an operational lever worth monitoring for payer negotiations, formulary changes, or shifts in clinical practice that could materially affect revenue.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

14 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,610	$690	$1.8M
J2777	Injection, faricimab‑svoa, 0.1 mg	26,520	$30	$769.1K
J2778	Injection, ranibizumab, 0.1 mg	3,750	$180	$674.3K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	3,560	$90	$323.9K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,620	$100	$261.7K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	4,080	$30	$126.4K
J9035	Injection, bevacizumab, 10 mg	890	$60	$49.6K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	220	$120	$26.5K
67041	In this procedure, the provider removes scar tissue from the retinal membrane that obscures vision. He removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical…	20	$850	$14.5K
67108	The provider repairs a detached retina using heat produced by a laser beam or by freezing the tissues. He may attach a scleral buckle to simplify the passage of fluid through and behind the retina or…	10	$940	$13.2K

Showing 1–10 of 14

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 14 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Wyoming Distribution

Douglas Holmes — 6 of 14 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Wyoming

Full comparison — all codes billed, vs. state median

14 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	1	10	1,490	$690	$1M
J2777	1	10	26,520	$30	$771.6K
J2778	1	10	3,750	$180	$674.7K
67028	1	10	1,470	$100	$143.7K
J9035	1	10	510	$60	$28.4K
92014	1	80	190	$80	$21.5K
67108	2	10	20	$1,250	$19.9K
67041	1	10	20	$1,080	$16.1K
99214	349	780	100	$80	$14.8K
92235	1	10	70	$110	$7K

Showing 1–10 of 14

Related Providers

Other providers that share a Tax Identification Number (TIN) with Douglas Holmes, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Nathan Steinle	CA	Retina Specialist (Ophthalmology) Physician	$9.5M	$0
Prema Abraham	SD	Retina Specialist (Ophthalmology) Physician	$7.1M	$0
Kyle Thompson	ID	Retina Specialist (Ophthalmology) Physician	$4.5M	$0
Mitchell Goff	UT	Retina Specialist (Ophthalmology) Physician	$3.8M	$0
Brittney Statler	CO	Ophthalmology Physician	$3.7M	$0
Arthur Korotkin	CO	Ophthalmology Physician	$3.7M	$0
Richard Kinsey	TN	Anatomic Pathology & Clinical Pathology Physician	$3.3M	$147.3K
Brendan Girschek	AZ	Ophthalmology Physician	$3.2M	$0
John Bormes	SD	Ophthalmology Physician	$2.6M	$0
John Purviance	WY	Radiation Oncology Physician	$2.5M	$0

Nearby Providers

Other providers in the same ZIP code as Douglas Holmes, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
University Of Wyoming	WY	Federally Qualified Health Center (FQHC)	$0	$14.8M
Bear Country Home Healthcare	WY	Home Health Agency	$0	$7.8M
Wyoming Independent Living Rehabilitation, Inc.	WY	Case Management Agency	$0	$4.7M
Wyoming Medical Center Inc	WY	General Acute Care Hospital	$0	$4.4M
Emergency Medical Physicians PC	WY	Emergency Medicine Physician	$0	$4.1M
Acm Therapy Group LLC	WY	Occupational Therapist	$0	$3.6M
Emg Casper Pp LLC	WY	Assisted Living Facility	$0	$3.5M
Renewed Hope Foundation, Inc.	WY	Physical Therapist	$0	$2.6M
Optimal Physical Therapy, LLC	WY	Physical Therapy Clinic/Center	$0	$2.5M
Cedar Ridge Child And Family Counseling	WY	Clinical Psychologist	$0	$2.4M

Douglas Holmes — Billing Profile & Reimbursement Data

Sign up for Douglas Holmes — Billing Profile & Reimbursement Data policy alerts

Douglas Holmes — Billing Profile & Reimbursement Data

Sign up for Douglas Holmes — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References